Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors

Brain tumors are particularly aggressive and represent a significant cause of morbidity and mortality in adults and children, affecting the global population and being responsible for 2.6% of all cancer deaths (as well as 30% of those in children and 20% in young adults). The blood-brain barrier (BB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giovanna Calabrese, Giovanna De Luca, Giuseppe Nocito, Maria Giovanna Rizzo, Sofia Paola Lombardo, Giulia Chisari, Stefano Forte, Emanuele Luigi Sciuto, Sabrina Conoci
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/28c78dabb43e4319886b33bba847ccfe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:28c78dabb43e4319886b33bba847ccfe
record_format dspace
spelling oai:doaj.org-article:28c78dabb43e4319886b33bba847ccfe2021-11-11T17:13:58ZCarbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors10.3390/ijms2221117831422-00671661-6596https://doaj.org/article/28c78dabb43e4319886b33bba847ccfe2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11783https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Brain tumors are particularly aggressive and represent a significant cause of morbidity and mortality in adults and children, affecting the global population and being responsible for 2.6% of all cancer deaths (as well as 30% of those in children and 20% in young adults). The blood-brain barrier (BBB) excludes almost 100% of the drugs targeting brain neoplasms, representing one of the most significant challenges to current brain cancer therapy. In the last decades, carbon dots have increasingly played the role of drug delivery systems with theranostic applications against cancer, thanks to their bright photoluminescence, solubility in bodily fluids, chemical stability, and biocompatibility. After a summary outlining brain tumors and the current drug delivery strategies devised in their therapeutic management, this review explores the most recent literature about the advances and open challenges in the employment of carbon dots as both diagnostic and therapeutic agents in the treatment of brain cancers, together with the strategies devised to allow them to cross the BBB effectively.Giovanna CalabreseGiovanna De LucaGiuseppe NocitoMaria Giovanna RizzoSofia Paola LombardoGiulia ChisariStefano ForteEmanuele Luigi SciutoSabrina ConociMDPI AGarticlebrain tumorsdrug-delivery systemsblood-brain barriernanoparticlescarbon dotsnanocarriersBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11783, p 11783 (2021)
institution DOAJ
collection DOAJ
language EN
topic brain tumors
drug-delivery systems
blood-brain barrier
nanoparticles
carbon dots
nanocarriers
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle brain tumors
drug-delivery systems
blood-brain barrier
nanoparticles
carbon dots
nanocarriers
Biology (General)
QH301-705.5
Chemistry
QD1-999
Giovanna Calabrese
Giovanna De Luca
Giuseppe Nocito
Maria Giovanna Rizzo
Sofia Paola Lombardo
Giulia Chisari
Stefano Forte
Emanuele Luigi Sciuto
Sabrina Conoci
Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
description Brain tumors are particularly aggressive and represent a significant cause of morbidity and mortality in adults and children, affecting the global population and being responsible for 2.6% of all cancer deaths (as well as 30% of those in children and 20% in young adults). The blood-brain barrier (BBB) excludes almost 100% of the drugs targeting brain neoplasms, representing one of the most significant challenges to current brain cancer therapy. In the last decades, carbon dots have increasingly played the role of drug delivery systems with theranostic applications against cancer, thanks to their bright photoluminescence, solubility in bodily fluids, chemical stability, and biocompatibility. After a summary outlining brain tumors and the current drug delivery strategies devised in their therapeutic management, this review explores the most recent literature about the advances and open challenges in the employment of carbon dots as both diagnostic and therapeutic agents in the treatment of brain cancers, together with the strategies devised to allow them to cross the BBB effectively.
format article
author Giovanna Calabrese
Giovanna De Luca
Giuseppe Nocito
Maria Giovanna Rizzo
Sofia Paola Lombardo
Giulia Chisari
Stefano Forte
Emanuele Luigi Sciuto
Sabrina Conoci
author_facet Giovanna Calabrese
Giovanna De Luca
Giuseppe Nocito
Maria Giovanna Rizzo
Sofia Paola Lombardo
Giulia Chisari
Stefano Forte
Emanuele Luigi Sciuto
Sabrina Conoci
author_sort Giovanna Calabrese
title Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
title_short Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
title_full Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
title_fullStr Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
title_full_unstemmed Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors
title_sort carbon dots: an innovative tool for drug delivery in brain tumors
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/28c78dabb43e4319886b33bba847ccfe
work_keys_str_mv AT giovannacalabrese carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT giovannadeluca carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT giuseppenocito carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT mariagiovannarizzo carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT sofiapaolalombardo carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT giuliachisari carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT stefanoforte carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT emanueleluigisciuto carbondotsaninnovativetoolfordrugdeliveryinbraintumors
AT sabrinaconoci carbondotsaninnovativetoolfordrugdeliveryinbraintumors
_version_ 1718432107380867072